These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6462093)

  • 21. Severe combined immunodeficiency with cartilage-hair hypoplasa: in vitro response to thymosin and attempted reconstitution.
    Steele RW; Britton HA; Anderson CT; Kniker WT
    Pediatr Res; 1976 Dec; 10(12):1003-5. PubMed ID: 995498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte responsiveness to thymosin in angioimmunoblastic lymphadenopathy with lymphomatous transformation.
    Taylor SG
    Med Pediatr Oncol; 1982; 10(2):171-4. PubMed ID: 6978456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymosin and the endocrine thymus.
    Schulof RS; Goldstein AL
    Adv Intern Med; 1977; 22():121-43. PubMed ID: 320839
    [No Abstract]   [Full Text] [Related]  

  • 24. Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium.
    Horowitz S; Borcherding W; Moorthy AV; Chesney R; Schulte-Wisserman H; Hong R
    Science; 1977 Sep; 197(4307):999-1001. PubMed ID: 302032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of in vitro generation of cell-mediated cytotoxicity. In vitro induction of suppressor T lymphocytes by thymosin.
    Marshall GD; Thurman GB; Goldstein AL
    J Reticuloendothel Soc; 1980 Aug; 28(2):141-9. PubMed ID: 6447785
    [No Abstract]   [Full Text] [Related]  

  • 26. Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.
    Mastino A; Favalli C; Grelli S; Innocenti F; Garaci E
    Cell Immunol; 1991 Mar; 133(1):196-205. PubMed ID: 1991327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymosin treatment of children with primary immunodeficiency disease.
    Wara DW; Ammann AJ
    Transplant Proc; 1978 Mar; 10(1):203-9. PubMed ID: 305674
    [No Abstract]   [Full Text] [Related]  

  • 28. MicroELISA detection of thymosin alpha 1 released in thymic organ cultures.
    Sinopoli NT; Pesce A; Baldassarre AM; Trivers GE; Frati L; Rinaldi-Garaci C
    J Immunol Methods; 1988 Jun; 110(2):261-5. PubMed ID: 3379314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of thymic hormones in cancer diagnosis and treatment.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Int J Immunopharmacol; 2000 Apr; 22(4):261-73. PubMed ID: 10689100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymosin modulation of regulatory T cell function.
    Mutchnick MG; Prieto JA; Schaffner JA; Weller FE
    Clin Immunol Immunopathol; 1982 Jun; 23(3):626-33. PubMed ID: 6214350
    [No Abstract]   [Full Text] [Related]  

  • 31. Recovery of T-cell functions in aged mice injected with synthetic thymosin-alpha 1.
    Frasca D; Garavini M; Doria G
    Cell Immunol; 1982 Sep; 72(2):384-91. PubMed ID: 6758954
    [No Abstract]   [Full Text] [Related]  

  • 32. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 33. T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides.
    Ahmed A; Wong DM; Thurman GB; Low TL; Goldstein AL; Sharkis SJ; Goldschneider I
    Ann N Y Acad Sci; 1979; 332():81-94. PubMed ID: 316987
    [No Abstract]   [Full Text] [Related]  

  • 34. Circulating thymulin and thymosin-alpha 1 activity in pediatric acquired immune deficiency syndrome: in vivo and in vitro studies.
    Rubinstein A; Novick BE; Sicklick MJ; Bernstein LJ; Incefy GS; Naylor PH; Goldstein AL
    J Pediatr; 1986 Sep; 109(3):422-7. PubMed ID: 3018210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and immunological effects of thymosin alpha 1 and its fragments on inhibitory factor in minimal change nephrotic syndrome.
    Abiko T; Onodera I; Sekino H
    Chem Pharm Bull (Tokyo); 1980 Dec; 28(12):3542-8. PubMed ID: 7226295
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of thymosin on glucocorticoid receptors in lymphoid cells.
    Osheroff PL
    Cell Immunol; 1981 May; 60(2):376-85. PubMed ID: 6972268
    [No Abstract]   [Full Text] [Related]  

  • 37. [The thymus gland and autoimmune diseases].
    Klug H
    Z Gesamte Inn Med; 1973 Aug; 28(15):441-50. PubMed ID: 4587798
    [No Abstract]   [Full Text] [Related]  

  • 38. Biological response modifiers and their promise in clinical medicine.
    Attallah AM; Yeatman TJ; Johnson RP; Petricciani JC
    Pharmacol Ther; 1982; 19(3):435-54. PubMed ID: 6201933
    [No Abstract]   [Full Text] [Related]  

  • 39. CONTRASTING ABNORMALITIES IN THE THYMUS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND MYASTHENIA GRAVIS: A QUANTITATIVE HISTOLOGICAL STUDY.
    GOLDSTEIN G; MACKAY IR
    Aust J Exp Biol Med Sci; 1965 Jul; 43():381-90. PubMed ID: 14343498
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA; McCune WJ
    Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.